Side-by-side financials for ADVB and CAI. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADVB | CAI |
|---|---|---|
| Market cap | - | $4.93 B |
| US-listed rank | - | #1401 |
| Revenue (latest FY) | - | $812.03M |
| Net income (latest FY) | -$3.26M | -$68.09M |
| Net margin | - | -8.4% |
| SEC filings | 87 | 102 |
Full pages: Advanced Biomed Inc. and Caris Life Sciences, Inc., or browse the full rankings.